RecruitingNCT03402919

Comprehensive Assessment of Neurodegeneration and Dementia

The Comprehensive Assessment of Neurodegeneration and Dementia Study

Sponsor

McGill University

Enrollment

1,573 participants

Start Date

Jun 1, 2016

Study Type

OBSERVATIONAL

Conditions

Dementia Mild Cognitive Impairment (MCI)Subjective Cognitive Impairment Lewy Body Disease(LBD)Alzheimer Disease (AD)Frontotemporal Dementia (FTD)Subjective Cognitive Decline (SCD)Mixed Dementia Parkinson's Disease (PD)Cognitively Unimpaired

Summary

This is a longitudinal observational study recruiting individuals between the ages of 50 and 90 with different types of dementia as well as a comparison group without cognitive deficits. Participants are/will be recruited at sites across Canada and will undergo assessments, neuroimaging, and biological sample collection.

Eligibility

Min Age: 50 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting detailed information — including brain scans, blood tests, and memory tests — from people with various stages of memory or thinking problems, to better understand and track how conditions like Alzheimer's disease develop over time. **You may be eligible if...** - You have noticed changes in your memory or thinking, or a doctor has detected them - You speak English or French well enough to complete questionnaires and tests - You live close enough to a study site - You have a family member or close friend who can provide additional information about your condition - You have up to 12 years of education - You fit into one of the study groups: normal cognition, subjective concerns about memory, or mild impairment **You may NOT be eligible if...** - You are unable to provide informed consent (a caregiver may be able to consent in some locations) - You do not have a study partner who can participate - You cannot travel to the study site Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(19)

University of Calgary

Calgary, Alberta, Canada

University of Alberta Hospital

Edmonton, Alberta, Canada

Djavad Mowafaghian Centre for Brain Health

Vancouver, British Columbia, Canada

Island Health

Victoria, British Columbia, Canada

Veteran's Memorial Building

Halifax, Nova Scotia, Canada

Hamilton General Hospital

Hamilton, Ontario, Canada

St. Joseph's Health Care London

London, Ontario, Canada

Gait and Brain Lab

London, Ontario, Canada

Bruyère Research Institute

Ottawa, Ontario, Canada

Kawartha Centre

Peterborough, Ontario, Canada

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

University Health Network Memory Clinic

Toronto, Ontario, Canada

Baycrest Clinical Unit

Toronto, Ontario, Canada

University of Waterloo

Waterloo, Ontario, Canada

Research Institute of the McGill University Health Centre

Montreal, Quebec, Canada

Jewish General Hospital/McGill Memory Clinic

Montreal, Quebec, Canada

Clinique de cognition Institut universitaire de gériatrie de Montréal

Montreal, Quebec, Canada

Hôpital Enfant-Jésus

Québec, Quebec, Canada

Centre de recherche sur le vieillissement CIUSSS de l'Estrie-CHUS

Sherbrooke, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03402919

Related Trials

Genetic Characterization of Movement Disorders and Dementias

NCT020142461 location

Non-invasive Stimulation of Deep Brain Structures to Modulate Working Memory

NCT075609041 location

Personalized Digital Training for COGnitive FITness in Mild Cognitive Impairment

NCT072864482 locations

A Study of Buntanetap in Participants With PD

NCT0728478427 locations

Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias

NCT030358511 location